Why Is Planet Labs Stock Up Today?
Planet Labs (NYSE: PL) opened Friday trading with an unmistakable…
Sell
32
PJP Quote, Financials, Valuation and Earnings
Last price:
$79.55
Seasonality move
:
4.41%
Day range:
$80.08 - $80.73
52-week range:
$72.25 - $89.87
Dividend yield:
1.2%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
6.7K
Avg. volume:
8.5K
1-year change:
-2.53%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | -- | -- | -- | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | -- | -- | -- | -- |
|
XHE
SPDR S&P Health Care Equipment ETF
|
-- | -- | -- | -- | -- |
|
XPH
SPDR S&P Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
PJP
Invesco Pharmaceuticals ETF
|
$80.30 | -- | -- | -- | $0.27 | 1.2% | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
$161.84 | -- | -- | -- | $1.17 | 0.73% | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
$64.07 | -- | -- | -- | $0.13 | 0.26% | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
$29.05 | -- | -- | -- | $0.06 | 0.77% | -- |
|
XHE
SPDR S&P Health Care Equipment ETF
|
$80.61 | -- | -- | -- | $0.02 | 0.07% | -- |
|
XPH
SPDR S&P Pharmaceuticals ETF
|
$41.07 | -- | -- | -- | $0.10 | 1.46% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
PJP
Invesco Pharmaceuticals ETF
|
-- | 0.292 | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | 0.751 | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | 0.936 | -- | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | 0.845 | -- | -- |
|
XHE
SPDR S&P Health Care Equipment ETF
|
-- | 1.425 | -- | -- |
|
XPH
SPDR S&P Pharmaceuticals ETF
|
-- | 0.378 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | -- | -- | -- | -- | -- |
|
RSPH
Invesco S&P 500 Eql Wght Health Care ETF
|
-- | -- | -- | -- | -- | -- |
|
XHE
SPDR S&P Health Care Equipment ETF
|
-- | -- | -- | -- | -- | -- |
|
XPH
SPDR S&P Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
Invesco Pharmaceuticals ETF vs. Competitors
-
Which has Higher Returns PJP or FBT?
First Trust NYSE Arca Biotechnology Index Fund has a net margin of -- compared to Invesco Pharmaceuticals ETF's net margin of --. Invesco Pharmaceuticals ETF's return on equity of -- beat First Trust NYSE Arca Biotechnology Index Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PJPInvesco Pharmaceuticals ETF-- -- -- FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- -
What do Analysts Say About PJP or FBT?
Invesco Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust NYSE Arca Biotechnology Index Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Pharmaceuticals ETF has higher upside potential than First Trust NYSE Arca Biotechnology Index Fund, analysts believe Invesco Pharmaceuticals ETF is more attractive than First Trust NYSE Arca Biotechnology Index Fund.
Company Buy Ratings Hold Ratings Sell Ratings PJPInvesco Pharmaceuticals ETF0 0 0 FBTFirst Trust NYSE Arca Biotechnology Index Fund0 0 0 -
Is PJP or FBT More Risky?
Invesco Pharmaceuticals ETF has a beta of 0.506, which suggesting that the stock is 49.427% less volatile than S&P 500. In comparison First Trust NYSE Arca Biotechnology Index Fund has a beta of 0.647, suggesting its less volatile than the S&P 500 by 35.317%.
-
Which is a Better Dividend Stock PJP or FBT?
Invesco Pharmaceuticals ETF has a quarterly dividend of $0.27 per share corresponding to a yield of 1.2%. First Trust NYSE Arca Biotechnology Index Fund offers a yield of 0.73% to investors and pays a quarterly dividend of $1.17 per share. Invesco Pharmaceuticals ETF pays -- of its earnings as a dividend. First Trust NYSE Arca Biotechnology Index Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PJP or FBT?
Invesco Pharmaceuticals ETF quarterly revenues are --, which are smaller than First Trust NYSE Arca Biotechnology Index Fund quarterly revenues of --. Invesco Pharmaceuticals ETF's net income of -- is lower than First Trust NYSE Arca Biotechnology Index Fund's net income of --. Notably, Invesco Pharmaceuticals ETF's price-to-earnings ratio is -- while First Trust NYSE Arca Biotechnology Index Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Pharmaceuticals ETF is -- versus -- for First Trust NYSE Arca Biotechnology Index Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PJPInvesco Pharmaceuticals ETF-- -- -- -- FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- --
-
Which has Higher Returns PJP or PBE?
Invesco Biotechnology & Genome ETF has a net margin of -- compared to Invesco Pharmaceuticals ETF's net margin of --. Invesco Pharmaceuticals ETF's return on equity of -- beat Invesco Biotechnology & Genome ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PJPInvesco Pharmaceuticals ETF-- -- -- PBEInvesco Biotechnology & Genome ETF-- -- -- -
What do Analysts Say About PJP or PBE?
Invesco Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Biotechnology & Genome ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Pharmaceuticals ETF has higher upside potential than Invesco Biotechnology & Genome ETF, analysts believe Invesco Pharmaceuticals ETF is more attractive than Invesco Biotechnology & Genome ETF.
Company Buy Ratings Hold Ratings Sell Ratings PJPInvesco Pharmaceuticals ETF0 0 0 PBEInvesco Biotechnology & Genome ETF0 0 0 -
Is PJP or PBE More Risky?
Invesco Pharmaceuticals ETF has a beta of 0.506, which suggesting that the stock is 49.427% less volatile than S&P 500. In comparison Invesco Biotechnology & Genome ETF has a beta of 0.809, suggesting its less volatile than the S&P 500 by 19.078%.
-
Which is a Better Dividend Stock PJP or PBE?
Invesco Pharmaceuticals ETF has a quarterly dividend of $0.27 per share corresponding to a yield of 1.2%. Invesco Biotechnology & Genome ETF offers a yield of 0.26% to investors and pays a quarterly dividend of $0.13 per share. Invesco Pharmaceuticals ETF pays -- of its earnings as a dividend. Invesco Biotechnology & Genome ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PJP or PBE?
Invesco Pharmaceuticals ETF quarterly revenues are --, which are smaller than Invesco Biotechnology & Genome ETF quarterly revenues of --. Invesco Pharmaceuticals ETF's net income of -- is lower than Invesco Biotechnology & Genome ETF's net income of --. Notably, Invesco Pharmaceuticals ETF's price-to-earnings ratio is -- while Invesco Biotechnology & Genome ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Pharmaceuticals ETF is -- versus -- for Invesco Biotechnology & Genome ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PJPInvesco Pharmaceuticals ETF-- -- -- -- PBEInvesco Biotechnology & Genome ETF-- -- -- --
-
Which has Higher Returns PJP or RSPH?
Invesco S&P 500 Eql Wght Health Care ETF has a net margin of -- compared to Invesco Pharmaceuticals ETF's net margin of --. Invesco Pharmaceuticals ETF's return on equity of -- beat Invesco S&P 500 Eql Wght Health Care ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PJPInvesco Pharmaceuticals ETF-- -- -- RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- -
What do Analysts Say About PJP or RSPH?
Invesco Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco S&P 500 Eql Wght Health Care ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Pharmaceuticals ETF has higher upside potential than Invesco S&P 500 Eql Wght Health Care ETF, analysts believe Invesco Pharmaceuticals ETF is more attractive than Invesco S&P 500 Eql Wght Health Care ETF.
Company Buy Ratings Hold Ratings Sell Ratings PJPInvesco Pharmaceuticals ETF0 0 0 RSPHInvesco S&P 500 Eql Wght Health Care ETF0 0 0 -
Is PJP or RSPH More Risky?
Invesco Pharmaceuticals ETF has a beta of 0.506, which suggesting that the stock is 49.427% less volatile than S&P 500. In comparison Invesco S&P 500 Eql Wght Health Care ETF has a beta of 0.879, suggesting its less volatile than the S&P 500 by 12.149%.
-
Which is a Better Dividend Stock PJP or RSPH?
Invesco Pharmaceuticals ETF has a quarterly dividend of $0.27 per share corresponding to a yield of 1.2%. Invesco S&P 500 Eql Wght Health Care ETF offers a yield of 0.77% to investors and pays a quarterly dividend of $0.06 per share. Invesco Pharmaceuticals ETF pays -- of its earnings as a dividend. Invesco S&P 500 Eql Wght Health Care ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PJP or RSPH?
Invesco Pharmaceuticals ETF quarterly revenues are --, which are smaller than Invesco S&P 500 Eql Wght Health Care ETF quarterly revenues of --. Invesco Pharmaceuticals ETF's net income of -- is lower than Invesco S&P 500 Eql Wght Health Care ETF's net income of --. Notably, Invesco Pharmaceuticals ETF's price-to-earnings ratio is -- while Invesco S&P 500 Eql Wght Health Care ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Pharmaceuticals ETF is -- versus -- for Invesco S&P 500 Eql Wght Health Care ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PJPInvesco Pharmaceuticals ETF-- -- -- -- RSPHInvesco S&P 500 Eql Wght Health Care ETF-- -- -- --
-
Which has Higher Returns PJP or XHE?
SPDR S&P Health Care Equipment ETF has a net margin of -- compared to Invesco Pharmaceuticals ETF's net margin of --. Invesco Pharmaceuticals ETF's return on equity of -- beat SPDR S&P Health Care Equipment ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PJPInvesco Pharmaceuticals ETF-- -- -- XHESPDR S&P Health Care Equipment ETF-- -- -- -
What do Analysts Say About PJP or XHE?
Invesco Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P Health Care Equipment ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Pharmaceuticals ETF has higher upside potential than SPDR S&P Health Care Equipment ETF, analysts believe Invesco Pharmaceuticals ETF is more attractive than SPDR S&P Health Care Equipment ETF.
Company Buy Ratings Hold Ratings Sell Ratings PJPInvesco Pharmaceuticals ETF0 0 0 XHESPDR S&P Health Care Equipment ETF0 0 0 -
Is PJP or XHE More Risky?
Invesco Pharmaceuticals ETF has a beta of 0.506, which suggesting that the stock is 49.427% less volatile than S&P 500. In comparison SPDR S&P Health Care Equipment ETF has a beta of 1.055, suggesting its more volatile than the S&P 500 by 5.483%.
-
Which is a Better Dividend Stock PJP or XHE?
Invesco Pharmaceuticals ETF has a quarterly dividend of $0.27 per share corresponding to a yield of 1.2%. SPDR S&P Health Care Equipment ETF offers a yield of 0.07% to investors and pays a quarterly dividend of $0.02 per share. Invesco Pharmaceuticals ETF pays -- of its earnings as a dividend. SPDR S&P Health Care Equipment ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PJP or XHE?
Invesco Pharmaceuticals ETF quarterly revenues are --, which are smaller than SPDR S&P Health Care Equipment ETF quarterly revenues of --. Invesco Pharmaceuticals ETF's net income of -- is lower than SPDR S&P Health Care Equipment ETF's net income of --. Notably, Invesco Pharmaceuticals ETF's price-to-earnings ratio is -- while SPDR S&P Health Care Equipment ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Pharmaceuticals ETF is -- versus -- for SPDR S&P Health Care Equipment ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PJPInvesco Pharmaceuticals ETF-- -- -- -- XHESPDR S&P Health Care Equipment ETF-- -- -- --
-
Which has Higher Returns PJP or XPH?
SPDR S&P Pharmaceuticals ETF has a net margin of -- compared to Invesco Pharmaceuticals ETF's net margin of --. Invesco Pharmaceuticals ETF's return on equity of -- beat SPDR S&P Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PJPInvesco Pharmaceuticals ETF-- -- -- XPHSPDR S&P Pharmaceuticals ETF-- -- -- -
What do Analysts Say About PJP or XPH?
Invesco Pharmaceuticals ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Invesco Pharmaceuticals ETF has higher upside potential than SPDR S&P Pharmaceuticals ETF, analysts believe Invesco Pharmaceuticals ETF is more attractive than SPDR S&P Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings PJPInvesco Pharmaceuticals ETF0 0 0 XPHSPDR S&P Pharmaceuticals ETF0 0 0 -
Is PJP or XPH More Risky?
Invesco Pharmaceuticals ETF has a beta of 0.506, which suggesting that the stock is 49.427% less volatile than S&P 500. In comparison SPDR S&P Pharmaceuticals ETF has a beta of 0.626, suggesting its less volatile than the S&P 500 by 37.401%.
-
Which is a Better Dividend Stock PJP or XPH?
Invesco Pharmaceuticals ETF has a quarterly dividend of $0.27 per share corresponding to a yield of 1.2%. SPDR S&P Pharmaceuticals ETF offers a yield of 1.46% to investors and pays a quarterly dividend of $0.10 per share. Invesco Pharmaceuticals ETF pays -- of its earnings as a dividend. SPDR S&P Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PJP or XPH?
Invesco Pharmaceuticals ETF quarterly revenues are --, which are smaller than SPDR S&P Pharmaceuticals ETF quarterly revenues of --. Invesco Pharmaceuticals ETF's net income of -- is lower than SPDR S&P Pharmaceuticals ETF's net income of --. Notably, Invesco Pharmaceuticals ETF's price-to-earnings ratio is -- while SPDR S&P Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Invesco Pharmaceuticals ETF is -- versus -- for SPDR S&P Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PJPInvesco Pharmaceuticals ETF-- -- -- -- XPHSPDR S&P Pharmaceuticals ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Coherent Stock Breaking Out?
Coherent (NYSE: COHR) has spent the better part of two years…
What Is The Long-term Outlook for AMC Stock?
Meme stock extraordinaire AMC Entertainment Holdings, Inc. (NYSE:AMC) has long…
Stock Ideas
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 53x
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 42x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
95
AVAV alert for Jun 27
AeroVironment [AVAV] is up 2.13% over the past day.
Buy
70
AEVA alert for Jun 27
Aeva Technologies [AEVA] is up 8.52% over the past day.
Buy
88
TSSI alert for Jun 27
TSS [TSSI] is down 2.73% over the past day.
